Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Gene Voss who wrote (7475)	4/26/1998 5:15:00 PM
From: Mkilloran	Respond to of 23519

Gene, ..when Viagra is actually launched by PFE they will have to list full disclosure...the warnings..that the general media has bypassed....also the backlash from ins co and the medical boards ....crack down on proper review/diag before patient is given a prescription for Viagara.. The script data for the next few months will tell the tale...

To: Gene Voss who wrote (7475)	4/26/1998 5:17:00 PM
From: Bradpalm1	Read Replies (1) \| Respond to of 23519

Gene, I have done the trial and I was pleasantly surprised by the results. Of course this was entirely subjective (since I have no dysfunction and I'm biased towards Viagra), but as I've said in the past, the sexual response originates in the mind and not in the genitals. Viagra has also been blessed with a wonderful package insert. This appears to be one of the safest and well tolerated medications released by the FDA in the last 12 months. I'm sure we'll start hearing about rare adverse events and stories as the weeks go by, but these patients were probably inappropiately started on the medication or used it inappropiately to begin with. As far as the formal launch is concerned, you obviously never took any marketing classes in school. Let's wait and see what happens. Bradpalm1